Allergies News and Research

Latest Allergies News and Research

Gilead, Bristol-Myers Squibb to develop and commercialize fixed-dose combination for HIV

Bristol-Myers Squibb Company and Gilead Sciences, Inc. today announced a licensing agreement for Bristol-Myers Squibb to develop and commercialize a fixed-dose combination containing Bristol-Myers Squibb's protease inhibitor REYATAZ (atazanavir sulfate) and Gilead's cobicistat, a pharmacoenhancing or "boosting" agent that increases blood levels of certain HIV medicines to potentially allow for one pill once daily dosing.

27 Oct 2011

Blood biomarker panel can predict survival in IPF patients

A panel of blood proteins can predict which patients with the progressive lung disease idiopathic pulmonary fibrosis (IPF) are likely to live at least five years or to die within two years, say researchers at the University of Pittsburgh School of Medicine and Centocor R&D.

27 Oct 2011

NeCEN centre for electron microscopy to open in Leiden

NeCEN, a new high quality centre for electron microscopy, opens its doors in Leiden on October 27th. NeCEN has two of the most advanced cryo-transmission electron microscopes worldwide.

24 Oct 2011

VTT to develop next-generation vaccines against allergy

VTT holds patents on gene technology which can be applied to alter the structure of an allergen, i.e. a protein causing allergy, so that it will cause less allergic symptoms than the original allergen, while remaining effective in desensitisation therapy.

22 Oct 2011

NIPPV helps decrease mortality rates among hospitalized COPD patients

Although increased use of noninvasive positive-pressure ventilation (NIPPV) nationwide has helped decrease mortality rates among patients hospitalized with chronic obstructive pulmonary disease (COPD), a small group of patients requiring subsequent treatment with invasive mechanical ventilation (IMV) have a significantly higher risk of death than those placed directly on IMV, according to researchers in the United States who studied patterns of NIPPV use.

22 Oct 2011

Nasal irrigation safe and effective for people with chronic sinus

Before reaching for an over-the-counter medication to relieve cold and allergy symptoms, try a simple source of relief that's been around for centuries.

21 Oct 2011

CMHDRE, DCSNO and CHF team up to help autistic children in New Orleans

The disappearance of reliable healthcare services in New Orleans following Hurricane Katrina left many children with asthma no choice but to seek treatment in emergency rooms across town - if they sought care at all. Xavier University of Louisiana's Center for Minority Health & Health Disparities Research and Education, Daughters of Charity Services of New Orleans and the Children's Health Fund have teamed up to reverse that trend by bringing reliable health care directly to these children.

21 Oct 2011

Breakthrough in development of effective therapy against Hendra virus

A team of Federal and university scientists reports a breakthrough in the development of an effective therapy against a deadly virus, Hendra virus. The results of their study, "A Neutralizing Human Monoclonal Antibody Protects African Green Monkeys from Hendra Virus Challenge," will appear in Science Translational Medicine online.

20 Oct 2011

Winter health and safety tips

Winter is a special time for celebration. It should also be a time for added caution if you or someone in your family is an older adult. It is the season for falls, slips on icy streets, and other dangers that can be especially harmful for older adults. "Something as simple as a fall can be devastating for older men and women," says Dr. Evelyn Granieri, director of the Division of Geriatrics at NewYork-Presbyterian Hospital/The Allen Hospital. "Before the cold weather arrives, it is important to prepare."

20 Oct 2011

SAIC receives NIAID contract to develop biopharmaceutical products for infectious diseases

Science Applications International Corporation (SAIC) announced today it was awarded a contract by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to provide preclinical services for the development of biopharmaceutical products for infectious diseases.

19 Oct 2011

Subjects with borderline elevated IgE levels less likely to develop glioma

A study published online Oct. 18 in the Journal of the National Cancer Institute provides some new but qualified support for the idea that the immune system's response to allergies may reduce the risk of developing deadly brain tumors.

19 Oct 2011

UEA scientists to assess future impact of global warming on allergic diseases

A new study by an international team of scientists including the University of East Anglia (UEA) will assess the future impact of global warming on allergic diseases.

18 Oct 2011

Overweight children more likely to develop asthma

Asthma is considered one of the main causes of school absenteeism and its prevalence has risen in the last decades. Overweight children have been shown to have double the frequency of asthma than that of non-obese children.

15 Oct 2011

Lifestyle factors and nutritional patterns reduce early causes of childhood allergy

Today, about one in four European children suffer from allergy, which makes this disease the non-infectious epidemic of the 21st century. Evidence suggests that lifestyle factors and nutritional patterns, such as breastfeeding, help to reduce the early symptoms of allergy.

15 Oct 2011

Engineered HBLs could prevent deadly allergic reactions

Researchers from the University of Notre Dame have announced a breakthrough approach to allergy treatment that inhibits food allergies, drug allergies, and asthmatic reactions without suppressing a sufferer's entire immunological system.

14 Oct 2011

Four companies receive NIAID contracts to develop broad-spectrum therapeutics

Four companies are to develop broad-spectrum therapeutics-antibiotics, antivirals and an antitoxin-to prevent or treat diseases caused by multiple types of bacteria or viruses, under contracts awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

14 Oct 2011

SWHR hosts Capitol Hill briefing, The War Within: Women and Autoimmunity

50:1, 9:1, 2:1 these are just some ratios of autoimmune disease disparities between women and men. The Society for Women's Health Research (SWHR) hosted the Capitol Hill briefing, The War Within: Women and Autoimmunity, on Tuesday, October 11 to address these concerns.

13 Oct 2011

Three key steps to prevent asthma attacks in children during winter

For most people, the word "autumn" conjures up images of honey crisp apples, pumpkin patches and Halloween. But for many pediatricians, fall also means more patients with asthma flare-ups.

13 Oct 2011

Peanut allergy could be switched off

Now researchers may have discovered how to switch off food allergies. Researchers from Northwestern University found a way to tweak the immune system so that it doesn’t react when foods like peanuts and eggs are encountered – in mice.

12 Oct 2011

TB rates decline for the first time: WHO report

According to Mario Raviglione, director of the World Health Organization (WHO)'s Stop TB program, for the first time, the number of people infected with tuberculosis (TB) each year is declining. He was speaking at a press conference to release Global Tuberculosis Control 2011, WHO's 16th annual report on TB, which summarizes advances made and challenges ahead. The report features data on TB in nearly 200 countries with treatment results and financing trends.

12 Oct 2011